Introduction {#s1}
============

Diabetes mellitus is characterized by high levels of blood glucose resulting from defects in insulin production, insulin action or both. The two main forms of diabetes are type 1 (T1D) and type 2 diabetes (T2D). Both types are characterized by progressive pancreatic β-cell loss, which is more marked in T1D [@pone.0003030-Cnop1]. β-cell death in T1D is mediated by a protracted autoimmune attack where apoptosis is triggered by cytokines and by other mechanisms such as Fas-FasL or granzyme B [@pone.0003030-Eizirik1], [@pone.0003030-Mathis1]. Previous microarray studies from our group indicate that β-cells up- and down-regulate complex gene networks in response to cytokines [@pone.0003030-Kutlu1], [@pone.0003030-Eizirik2]. This altered gene expression profile is regulated by key transcription factors such as NF-κB and STAT-1 [@pone.0003030-Cnop1], [@pone.0003030-Eizirik2] and is responsible for activation of pro-apoptotic execution pathways like endoplasmic reticulum (ER) stress, resulting in β-cell dysfunction and death [@pone.0003030-Eizirik3]. Of note, β-cells seem to have insufficient defense responses against some of these pro-inflammatory and pro-apoptosis pathways [@pone.0003030-Kharroubi1]--[@pone.0003030-Lenzen1]. As a whole, these observations indicate that signaling events occurring inside the β-cells are decisive for their survival or death in diabetes.

The Activator Protein-1 (AP-1) transcription factor is a key player in response to extracellular signals, including cytokines [@pone.0003030-Zenz1]. AP-1 is composed of a variety of dimers of JUN, FOS, ATF and MAF families. These components share biochemical properties but differ in their biological functions. AP-1 can induce cell survival or death under stress conditions, and it is the balance between the regulation of pro- and anti-apoptotic target genes which determines the cell outcome. This balance varies from cell to cell, and depends on both the activated AP-1 member(s) and on the parallel regulation of other transcription factors [@pone.0003030-Shaulian1]. Previous studies from our group indicate that the AP-1 subcomponent JunB is preferentially activated in human and rodent β-cells after cytokine exposure [@pone.0003030-Kutlu1], [@pone.0003030-Pirot1], [@pone.0003030-Ylipaasto1], but the role of this protein remains unclear. Here we investigated the effects of reducing or increasing JunB levels in insulin-producing INS-1E cells and in FACS-purified rat primary β-cells. We demonstrate that JunB counteracts cytokine-induced ER stress and apoptosis and might therefore be part of defense mechanisms triggered by β-cells during exposure to pro-inflammatory cytokines. Modulating JunB could represent a novel strategy to ameliorate β-cell resistance to immune damage.

Methods {#s2}
=======

Cell culture, treatments and nitric oxide (NO) measurement {#s2a}
----------------------------------------------------------

Pancreatic islets were isolated from adult Wistar rats (Charles River Laboratories Belgium, Brussels, Belgium), housed and used according to the guidelines of the Belgian Regulations for Animal Care; the Ethical Committee for Animal Experiments of the ULB approved the experimental protocols. Islets were isolated by collagenase digestion, β-cells were purified by autofluorescence-activated cell sorting (FACS, FACStar, Becton-Dickinson and Co.; Sunnyvale, CA, USA) and pre-cultured for 48 h in HAM\'s F-10 medium [@pone.0003030-Rasschaert1]. Insulin-producing INS-1E cells [@pone.0003030-Janjic1] were cultured in RPMI-1640 medium (Invitrogen, Paisley, UK) supplemented with 5% FCS. 3T3 *junB* ^−/−^ and 3T3 wild-type mouse fibroblasts [@pone.0003030-Passegue1] were cultured in Dulbecco\'s modified Eagle\'s medium (DMEM) supplemented with 10% FCS. Recombinant rat or mouse IFN-γ (100--500 U/ml, R&D Systems, Abingdon, UK) and human recombinant IL-1β (10--50 U/ml, gift from Dr. C.W. Reinolds, National Cancer Institute, Bethesda, MD, USA), and mouse TNF-α (1000 U/ml, Innogenetics, Gent, Belgium) were used. The NO blocker L-NMA (NG-methyl-L-arginine, Sigma, Steinheim, Germany) was used at 2.5 M. Culture medium was collected for nitrite determination (nitrite is a stable product of NO oxidation) by the Griess method [@pone.0003030-Kutlu1]. SP600125 and cyclopiazonic acid (CPA) (Sigma) were dissolved in DMSO and used at a concentration of 10 µM and 25 µM respectively. Cytokines, L-NMA, and CPA concentrations were selected based on our previous time course and dose-response studies [@pone.0003030-Eizirik1], [@pone.0003030-Kutlu1], [@pone.0003030-Pirot1].

Infection with recombinant adenoviruses {#s2b}
---------------------------------------

After 48 h pre-culture cells were infected either with AdLUC (control luciferase expressing virus), AdIκB^(SA)2^ (encoding a previously described NF-κB super-repressor protein [@pone.0003030-Heimberg1]) or AdJunB (expressing the rat JunB protein, purchased from RIKEN Bio Resource Center-Japan). Primary rat β-cells and INS-1E cells were infected for 2 h at 37°C with a MOI of 10 for AdIκB^(SA)2^ or AdLUC in INS-1E cells, and with a MOI of 20 and 40 for AdJunB and AdLUC in the INS-1E and primary β-cells, respectively.

Western blotting {#s2c}
----------------

Equal amounts of proteins were resolved by 10% SDS-PAGE. Immunoblot analysis was performed with antibodies against JunB, IkBα, inducible nitric oxide synthase (iNOS) and Chop (Santa Cruz Biotechnology, CA, USA), p-Jun N-terminal Kinase (JNK) and β-actin (Cell Signaling, Danvers, MA, USA) and α-tubulin (Sigma). The proteins were detected using the corresponding horseradish peroxidase-conjugated secondary antibody (Santa Cruz Biotechnology), and chemiluminescence Supersignal (Pierce, Rockford, IL, USA) quantified using Aida1D analysis software (Fujifilm). Values of the protein of interest were corrected for β-actin or α-tubulin. All Western blots shown in the figures are representative of at least 2--3 experiments.

Cell death assay {#s2d}
----------------

The percentage of cell death was determined by two observers, one of whom was unaware of sample identity, in ≥600 cells in each experimental condition by inverted fluorescence microscopy after addition of the DNA dyes Hoechst 33342 (20 µg/ml) and propidium iodide (10 µg/ml) (HO/PI) [@pone.0003030-Kutlu1]. This method is quantitative and has been validated in pancreatic β-cells by systematic comparisons with electron microscopy [@pone.0003030-Hoorens1], determination of DNA strand breaks [@pone.0003030-Kharroubi2] and caspase-3 activation [@pone.0003030-Eizirik2].

siRNA transfection {#s2e}
------------------

Cells were transfected overnight with 30 nM of siRNAs against JunB or Chop (sequences are provided in [Table S1](#pone.0003030.s005){ref-type="supplementary-material"}) or medium GC content inactive control siRNA (Invitrogen) using 1 µl of DharmaFECT™ lipid reagent (Dharmacon, Chicago, IL, USA) to 150 nM of siRNA in Opti-mem^R^ (Invitrogen). After overnight incubation, transfection medium was replaced by regular culture medium for cell recovery.

Real Time RT-PCR {#s2f}
----------------

mRNA expression was determined by real time RT-PCR using SYBR Green fluorescence on a LightCycler instrument (Roche, Manheim, Germany). Primer sequences for mouse and rat iNOS, ATF4, BiP, XBP-1s and Chop are provided in [Table S2](#pone.0003030.s006){ref-type="supplementary-material"}. Expression of the gene of interest was divided by the house keeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and expressed as fold induction compared to control. GAPDH expression is not modified under the present experimental conditions (data not shown).

Chromatin immunoprecipitation (ChIP) assay {#s2g}
------------------------------------------

ChIP assays were performed as described [@pone.0003030-Kouskouti1]. Extracts were precleared by 1 h incubation with protein A/Herring sperm DNA, and IP was performed by incubating overnight at 4°C with the JunB antibody (sc-73, Santa Cruz Biotechnology) or using preimmune serum as negative control. Primer sequences for the AP-1 sites within rat iNOS and Chop promoter are provided in [Table S3](#pone.0003030.s007){ref-type="supplementary-material"}.

Statistical analysis {#s2h}
--------------------

Data are shown as means±SEM, and comparisons between groups were made by paired *t* test or by ANOVA followed by *t* test with Bonferroni correction for multiple comparisons.

Results and Discussion {#s3}
======================

JunB protein expression and its phosphorylation were increased in insulin producing INS-1E cells as early as 2 hours after cytokine addition. This lasted for up to 12 h, returning to basal levels after 24 h ([Fig. 1A](#pone-0003030-g001){ref-type="fig"}). NO generated by the inducible form of iNOS is an important mediator of cytokine-driven changes in β-cell gene expression [@pone.0003030-Kutlu1]. JunB induction was not affected by the NO blocker L-NMA, indicating a direct cytokine effect independent of NO generation ([Fig. 1B](#pone-0003030-g001){ref-type="fig"}). NF-κB regulates JunB expression in fibroblasts and endothelial cells [@pone.0003030-Schmidt1], [@pone.0003030-Krappmann1]. Infection of INS-1E cells with the adenovirus AdIκB^(SA)2^ expressing an IκB "super-repressor" prevented cytokine-induced NF-κB nuclear translocation ([Fig. S1](#pone.0003030.s001){ref-type="supplementary-material"}) and abolished JunB induction ([Fig. 1C](#pone-0003030-g001){ref-type="fig"}), indicating that cytokine-mediated JunB activation in β-cells is regulated by NF-κB. It has been shown that JNK regulates the turnover of JunB through its accelerated degradation induced by JNK-mediated phosphorylation of the E3 ligase Itch [@pone.0003030-Gao1]. To examine whether JNK affects JunB stability, we exposed INS-1E cells to cytokines and/or the JNK inhibitor SP600125. We observed that reducing cytokine-mediated JNK activation leads to increased JunB protein expression ([Fig. 1D](#pone-0003030-g001){ref-type="fig"}), in agreement with data in other cell types [@pone.0003030-Gao1], [@pone.0003030-Gurzov1].

![Cytokine-induced JunB upregulation in INS-1E cells is mediated via NF-κB activation.\
(A) INS-1E cells were treated with IL-1β+IFN-γ and JunB protein expression was determined by Western blot at different time points. The two observed bands correspond to JunB and its phosphorylated form. (B) JunB expression after cytokines and/or L-NMA exposure. (C) INS-1E cells were infected with a recombinant adenovirus expressing either luciferase (AdLUC) or the NF-κB nondegradable inhibitor IkB^(SA)2^ (AdIκB^(SA)2^) and then exposed to IL-1β+IFN-γ. Expression of IκBα, IκBα^(SA)2^ and JunB were determined by Western blot. (D) INS-1E cells were treated with cytokines (IL-1β+IFN-γ) and/or the JNK inhibitor SP600125 at different time points as indicated, JunB and p-JNK expression were measured by Western blot.](pone.0003030.g001){#pone-0003030-g001}

To study the role of JunB in cytokine-mediated effects, we used RNAi technology to selectively knockdown JunB. Two different JunB siRNAs inhibited JunB protein expression by \>65% as compared with an inactive control siRNA in INS-1E cells ([Fig. 2A](#pone-0003030-g002){ref-type="fig"}, quantification in [Fig. S2](#pone.0003030.s002){ref-type="supplementary-material"}). JunB knockdown did not affect viability under basal conditions, but it increased cytokine-induced apoptosis by 2-fold at 24 h ([Fig. 2B](#pone-0003030-g002){ref-type="fig"}). The siRNA JunB-2, which induced a more marked knockdown effect, increased cytokine-mediated β-cell death to a larger extent. In line with these observations, primary β-cells were also sensitized to cytokine-induced apoptosis after JunB knockdown ([Fig. 2C,D](#pone-0003030-g002){ref-type="fig"}). Previous studies have shown that a *junB* transgene prevents liver apoptosis in *c-jun^−/−^* embryos [@pone.0003030-Passegue2], while JunB inactivation induces cell death in c-Jun knockout fibroblasts [@pone.0003030-Gurzov1]. To the best of our knowledge, there are no previous reports demonstrating a role of this protein in cytokine-mediated apoptosis.

![JunB knockdown augments cytokine-induced β-cell death.\
(A) INS-1E cells were transfected with inactive (Control) or two different active JunB siRNAs; Western blot for JunB was performed 8 h after cytokine exposure. Non-transfected cells (NT) were used as additional control. (B) Cytokines were added for 8 or 24 h to INS-1E cells and cell death was measured by HO/PI. (C) Purified rat β-cells were transfected with control or with JunB siRNAs, and Western blot for JunB was performed 8 h after cytokine addition. (D) JunB knockdown increases primary β-cell death 48 h after cytokine treatment. Results are the means±SEM of 3-5 independent experiments. *\*P\<*0.05, *\*\*P\<*0.01, *\*\*\*P\<*0.001.](pone.0003030.g002){#pone-0003030-g002}

Cytokine-induced iNOS expression in β-cells increases NO production, which has been shown to contribute to β-cell death [@pone.0003030-Eizirik1]. JunB knockdown potentiated iNOS mRNA and protein induction after cytokine treatment ([Fig. 3A,B](#pone-0003030-g003){ref-type="fig"}). Consistently, higher levels of the NO product nitrite were detected in the culture medium of cytokine-treated JunB knockdown cells ([Fig. 3C](#pone-0003030-g003){ref-type="fig"}). iNOS production is primarily controlled at the transcriptional level [@pone.0003030-Nathan1] and the *iNOS* promoter contains several binding sites for AP-1 [@pone.0003030-Chu1], [@pone.0003030-Hasselblatt1]. ChIP analysis using a JunB antibody demonstrated JunB binding to two of the five different putative AP-1 binding sites in the *iNOS* promoter ([Fig. 3D](#pone-0003030-g003){ref-type="fig"}). These data indicate that JunB might act as a direct transcriptional repressor of *iNOS* expression. To determine whether the effects of JunB are specific for pancreatic β-cells, we exposed wild-type or JunB knockout fibroblasts to cytokines. The treatment markedly increased iNOS expression and NO production leading to cell death in JunB knockout fibroblasts, but not in wild-type cells ([Fig. 3E--G](#pone-0003030-g003){ref-type="fig"}). Furthermore, L-NMA attenuated cytokine-induced apoptosis in *junB^−/−^* fibroblasts ([Fig. 3H](#pone-0003030-g003){ref-type="fig"}), suggesting that NO contributes for cell death in this model and that JunB prevents cytokine-mediated iNOS expression and NO toxicity in different cell types.

![JunB inactivation upregulates cytokine-induced iNOS expression.\
(A) INS-1E cells were transfected with control or JunB siRNAs and treated with cytokines. iNOS expression was examined at different time points by real time RT-PCR. (B) Western blot demonstrating increased expression of iNOS protein in the cytokine-treated JunB knockdown cells. (C) Nitrite accumulation in the culture medium. (D) Schematic representation of the rat iNOS promoter with putative AP-1 binding sites and the localization of the primers used. ChIP reveals binding of JunB to the iNOS promoter 4 h after cytokine treatment in two of the five putative AP-1 binding sites as assessed by PCR. (E) Wild-type or *junB^−/−^* fibroblasts were treated with cytokines (IL-1β+IFN-γ+TNF-α) for 24 h, JunB and iNOS expression were measured by Western blot. (F) Increased nitrite production by JunB knockout fibroblasts. (G) Cell death in fibroblasts as measured by HO/PI. (H) Cytokine-induced cell death in *junB^−/−^* fibroblasts was partially prevented by L-NMA. Results are the means±SEM of 3 independent experiments. *\*P\<*0.05.](pone.0003030.g003){#pone-0003030-g003}

IL-1β+IFN-γ decrease the expression of the sarco(endo)plasmic reticulum calcium ATPase (SERCA2) in β-cells via NO synthesis, thereby depleting ER Ca^2+^ stores and causing ER stress [@pone.0003030-Cardozo1]. The transcription factor Chop is a key regulator of ER stress--mediated apoptosis [@pone.0003030-Eizirik3], [@pone.0003030-Oyadomari1], [@pone.0003030-Oyadomari2]. Cytokines induce Chop expression in β-cells, and this was shown to be NO- and AP-1-dependent [@pone.0003030-Pirot1]. JunB knockdown induced an early upregulation of Chop mRNA and protein after cytokine addition ([Fig. 4A,B](#pone-0003030-g004){ref-type="fig"}). ChIP assay using primers designed to amplify the unique AP-1 site in the regulatory sequence of the *chop* gene [@pone.0003030-Pirot1] indicated strong JunB binding after cytokine treatment ([Fig. 4C](#pone-0003030-g004){ref-type="fig"}). This confirms physical interaction of JunB with the *chop* promoter, and suggests that JunB negatively regulates Chop expression, in agreement with our previous observation that mutation of the AP-1 site in the *chop* promoter increases basal activity, presumably by dissociating an inhibitory binding complex [@pone.0003030-Pirot1]. We next exposed INS-1E cells transfected with JunB siRNAs or fibroblasts lacking JunB to the chemical ER stressor CPA, a SERCA2 blocker that induces Chop and ER stress-mediated cell death independently of NO [@pone.0003030-Pirot1]. Addition of CPA increased Chop expression and apoptosis in JunB knockdown β-cells ([Fig. 4D,E](#pone-0003030-g004){ref-type="fig"}). Interestingly, *junB^−/−^* fibroblasts were also more sensitive to CPA-induced apoptosis and increased Chop mRNA and protein expression compared to wild-type cells ([Fig. S3A--C](#pone.0003030.s003){ref-type="supplementary-material"}). Chop expression was regulated at the promoter level as indicated by experiments using a *Chop* promoter luciferase reporter construct ([Fig. S3D](#pone.0003030.s003){ref-type="supplementary-material"}). These data indicate that JunB negatively modulates ER stress-induced Chop expression independently of NO induction, presumably via direct transcriptional repression. Chop knockdown by siRNA prevented CPA-induced apoptosis in *junB^−/−^* fibroblasts ([Fig. 4F,G](#pone-0003030-g004){ref-type="fig"}), indicating that Chop is a crucial mediator of ER stress-induced apoptosis. Importantly, JunB inactivation also increased expression of the ER stress markers BiP, XBP-1s and ATF4 after cytokine (INS-1E cells) or CPA treatment (INS-1E cells and fibroblasts) ([Figs. 5](#pone-0003030-g005){ref-type="fig"} and [6](#pone-0003030-g006){ref-type="fig"}) suggesting that all major pathways of the ER stress response are negatively regulated by JunB.

![Chop expression is upregulated in JunB knockdown and cytokine-treated cells.\
(A) RT-PCR of INS-1E cells transfected with control or JunB siRNAs and treated with cytokines. (B) Increased Chop protein expression after JunB knockdown and cytokine treatment was confirmed by Western blot. (C) Ethidium bromide-stained agarose gel of PCR products obtained with primers flanking the AP-1 binding site in the *Chop* promoter. After cytokine treatment, IP was done for JunB or control (−). (D) Chop mRNA expression is increased in JunB knockdown β-cells 15 h after the CPA (25 µM) addition. (E) Cell death in siRNA transfected INS-1E cells treated with CPA. (F) Fibroblasts were transfected with control or Chop siRNAs and Western blot for Chop was performed 24 h after CPA addition. Non-transfected cells (NT) were used as an additional control. (G) siRNA-mediated Chop knockdown decreased fibroblast cell death 24 h after CPA addition. Results are the means±SEM of 3 independent experiments. *\*P\<*0.05, *\*\*P\<*0.01, *\*\*\*P\<*0.001.](pone.0003030.g004){#pone-0003030-g004}

![Real time RT-PCR for ER stress markers in INS-1E cells after cytokines addition at the indicated time points (A) or 15 h CPA treatment (B).\
Results are the means±SEM of 3 independent experiments. *\*P\<*0.05.](pone.0003030.g005){#pone-0003030-g005}

![Real time RT-PCR for ER stress markers in fibroblasts 24 h after cytokine or CPA treatment.\
Results are the means±SEM of 3 independent experiments. *\*P\<*0.05.](pone.0003030.g006){#pone-0003030-g006}

Since JunB knockdown or knockout aggravated ER stress and apoptosis, we next examined whether overexpression of JunB protects β-cells from cytokine-induced cell death. JunB was overexpressed using an adenoviral vector containing the rat JunB cDNA [@pone.0003030-Kawakami1] under the control of the CAG promoter [@pone.0003030-Niwa1]. JunB protein expression was efficiently increased in INS-1E cells at the different multiplicity of infections (MOIs) tested ([Fig. 7A](#pone-0003030-g007){ref-type="fig"}); we selected MOI 20 for subsequent experiments. JunB overexpression reduced cytokine-mediated iNOS and Chop induction ([Fig. 7B,C](#pone-0003030-g007){ref-type="fig"}), and diminished nitrite production ([Fig. 7D](#pone-0003030-g007){ref-type="fig"}). In addition, INS-1E cells infected with AdJunB and exposed to cytokines or CPA displayed significantly decreased BiP but not XBP-1s or ATF4 expression ([Fig. S4](#pone.0003030.s004){ref-type="supplementary-material"}). Most importantly, prolonged JunB overexpression protected both INS-1E and primary β-cells against cytokine-induced apoptosis ([Fig. 7E--G](#pone-0003030-g007){ref-type="fig"}).

![Adenovirus-mediated overexpression of JunB protects INS-1E and primary β-cells from apoptosis after cytokine treatment.\
(A) Western blot showing JunB upregulation in INS-1E cells 24 h following infection with AdJunB at different MOIs. (B) iNOS and Chop mRNA expression in adenovirus-infected and cytokine-treated INS-1E cells was analyzed by real time PCR. (C) Western blot showing upregulation of JunB and downregulation of Chop and iNOS 24 h after infection of INS-1E cells with AdJunB compared with AdLUC (control) virus. (D) Nitrite accumulation in the medium of cells used in A. (E) Adenovirus-infected cells were exposed to cytokines for 24 h and cell death was measured with HO/PI. (F) Western blot showing JunB upregulation 48 h after infection of primary β-cells with AdJunB at different MOIs. (G) Percentage of cell death (HO/PI) after cytokine treatment in primary β-cells infected with AdJunB or control AdLUC. Results are the means±SEM of 3 independent experiments. *\*P\<*0.05, *\*\*P\<*0.01.](pone.0003030.g007){#pone-0003030-g007}

Taken together, our data show a cytokine-mediated early upregulation of JunB in β-cells. JunB induction is controlled by NF-κB, while its late return to base line is probably secondary to cytokine-triggered JNK activation and subsequent JunB degradation. It is thus conceivable that the previously reported pro-apoptotic role of JNK in cytokine-treated β-cells [@pone.0003030-Ammendrup1], [@pone.0003030-Mokhtari1] is at least partially mediated by JNK-induced JunB degradation (present data). It is noteworthy that while adenoviral-sustained overexpression of JunB protects β-cells against cytokine-mediated apoptosis ([Fig. 7](#pone-0003030-g007){ref-type="fig"}), endogenous cytokine-induced JunB expression fails to prevent cell death. This is probably related to the transitory nature of JunB expression, which peaks around 8 h and returns to baseline by 24 h after cytokine addition ([Fig. 1](#pone-0003030-g001){ref-type="fig"}), the time point when a significant increase in apoptosis is observed ([Fig. 2B](#pone-0003030-g002){ref-type="fig"}). Our results are in line with previous reports indicating that β-cell sensitivity to cytokine-induced cell death is aggravated by its feeble and/or transitory induction of protective genes such as XIAP [@pone.0003030-Kim1], Bcl-6 [@pone.0003030-Kharroubi1] or suppressor of cytokine signaling (SOCS)-3 [@pone.0003030-Karlsen2]. We show that JunB is a key regulator of the cytokine-induced ER stress response in β-cells. There are conflicting data, however, on whether cytokine-induced ER stress is relevant for β-cell apoptosis. Thus, while some studies indicate that upregulation of the chaperone BiP [@pone.0003030-Wang1] or blocking Chop [@pone.0003030-Eizirik3], [@pone.0003030-Oyadomari2] prevents cytokine-induced β-cell death, other studies failed to observe a protective effect of chemical chaperones and siRNA targeting Chop [@pone.0003030-Akerfeldt1] or described a dissociation between IL-1 induced ER stress and caspase-3 activity [@pone.0003030-Chambers1]. As described in [Fig. 8](#pone-0003030-g008){ref-type="fig"}, the protective mechanism of JunB in cytokine-induced β-cell apoptosis is mediated, at least in part, via inhibition of iNOS and ER stress markers expression. However, it is likely that JunB also regulates other pro- or anti-apoptotic pathways that remain to be determined.

![Proposed model for the role of JunB in cytokine- and CPA-mediated ER stress response.\
Cytokines induce a transitory JunB expression via NF-κB activation. JunB has an inhibitory role on iNOS and Chop expression and on other pro-ER stress and pro-apoptotic pathways that remain to be determined, favoring β-cell survival. Following prolonged exposure to cytokines, however, JunB turnover is induced by JNK and the pro-apoptotic effects of cytokines prevail. Prolonged overexpression of JunB using adenoviral vectors decreases cytokine-induced ER stress and β-cell apoptosis.](pone.0003030.g008){#pone-0003030-g008}

In conclusion, we demonstrate that JunB plays an unexpected protective role against cytokine-induced apoptosis in pancreatic β-cells. Knockdown of this AP-1 component aggravates cytokine-mediated cell death, whereas JunB overexpression protects β-cells from apoptosis. These findings suggest that increasing JunB expression could improve β-cell survival in early diabetes.

Supporting Information {#s4}
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###### 

Cells were plated in poly-lysine coated cover slips and, after 30 min treatment with cytokines, fixed with 4% paraformaldehyde and permeabilized with 70% acetone+30% methanol. Cells were then incubated for 1 h with anti-p65 antibody (sc-372, Santa Cruz Biotechnology) at 1:500 dilution. The secondary antibody FITC conjugated anti-rabbit IgG (Jackson ImmunoResearch; diluted 1:200) was used for visualization by inverted fluorescence microscopy (Zeiss Axiovert 200, Oberkochen-Germany). NF-κB activation was evaluated by presence of its p65 subunit in the nucleus. We have previously shown that p65 is the main constituent of NF-κB in cytokine-treated β-cells (Ortis F, Cardozo AK, Crispim D, Storling J, Mandrup-Poulsen T, et al. (2006) Cytokine-Induced Proapoptotic Gene Expression in Insulin-Producing Cells Is Related to Rapid, Sustained, and Nonoscillatory Nuclear Factor-κB Activation. Mol Endocrinol 20: 1867--1879).

(0.34 MB JPG)

###### 

Click here for additional data file.

###### 

Densitometry quantification of three experiments performed as shown in [Figure 2A](#pone-0003030-g002){ref-type="fig"}. \*P\<0.05, \*\*P\<0.01.

(0.37 MB TIF)

###### 

Click here for additional data file.

###### 

\(A\) Apoptosis is strongly induced by CPA in JunB KO fibroblasts. Wild-type or junB-/- fibroblasts were treated for 24 h with CPA (25 µM) and cell death was measured by HO/PI. Increased Chop mRNA (B) and protein (C) expression in JunB KO fibroblasts after CPA-induced ER stress was measured by respectively RT-PCR and Western blot. (D) The hamster Chop promoter (−782 to 21 bp) tethered to a luciferase reporter gene was used [@pone.0003030-Pirot1]. Fibroblasts were transfected using lipofectAMINE 2000 (Invitrogen) with 250 ng of the luciferase reporter construct and 50 ng of the pRL-CMV plasmid (used as internal control for transfection efficiency). Twenty-four hours after transfection cells were exposed for 24 h to CPA. Luciferase activities of cell lysates were determined and expressed as Firefly/Renilla (relative luciferase activity). \*P\<0.05, \*\*P\<0.01, \*\*\*P\<0.001.

(0.48 MB TIF)
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Click here for additional data file.
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Real time RT-PCR for ER stress markers in INS-1E after AdLUC or AdJunB infection and subsequent 24 h cytokine or CPA treatment. Results are the means±SEM of 3--6 independent experiments. \*P\<0.05, \*\*P\<0.01, \*\*\*P\<0.001.

(0.38 MB JPG)
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Click here for additional data file.

###### 

siRNA sequences for protein knockdown.

(0.03 MB DOC)
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Click here for additional data file.
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Primer sequences for real time RT-PCR.

(0.03 MB DOC)
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Click here for additional data file.

###### 

Primer sequences for analysis of JunB binding to the rat iNOS and Chop promoters in the ChIP studies performed.

(0.03 MB DOC)

###### 

Click here for additional data file.
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